Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection”

4,210 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,210 results

Not applicableUnknownNCT04836351
What this trial is testing

Rehabilitation for Patients With Persistent Symptoms Post COVID-19

Who this might be right for
Covid19
Western Norway University of Applied Sciences 20
Not applicableStudy completedNCT04647305
What this trial is testing

Effectiveness and Adherence to Closed Face Shields to Prevent COVID-19 Transmission

Who this might be right for
SARS-CoV-2 Infection
University of Los Andes, Columbia 233
Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Not applicableLooking for participantsNCT07278388
What this trial is testing

Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2

Who this might be right for
PASC Post Acute Sequelae of COVID 19Fatigue
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 200
Not applicableUnknownNCT04924894
What this trial is testing

Determinants of Obtaining Covid Vaccination Among Health Care Workers

Who this might be right for
COVID-19 Vaccination
Assiut University 350
Large-scale testing (Phase 3)Looking for participantsNCT04382846
What this trial is testing

Novel Regimens in COVID-19 Treatment

Who this might be right for
COVIDCorona Virus Infection
Tanta University 160
Testing effectiveness (Phase 2)Study completedNCT04993586
What this trial is testing

Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)

Who this might be right for
COVID-19 Lower Respiratory Infection
AnGes, Inc. 422
Testing effectiveness (Phase 2)Study completedNCT04566770
What this trial is testing

A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)

Who this might be right for
COVID-19
CanSino Biologics Inc. 480
Not applicableEnded earlyNCT04852770
What this trial is testing

Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics

Who this might be right for
Posttraumatic Stress DisorderCovid19
Fundação Bahiana de Infectologia 135
Testing effectiveness (Phase 2)UnknownNCT05047783
What this trial is testing

Masitinib in Patients With Symptomatic Mild to Moderate COVID-19

Who this might be right for
Covid19SARS-CoV2 InfectionCoronavirus Disease 2019
AB Science 78
Not applicableLooking for participantsNCT06585254
What this trial is testing

TVNS in Long COVID-19

Who this might be right for
Long COVIDChronic Fatigue Syndrome
Icahn School of Medicine at Mount Sinai 50
Not applicableStudy completedNCT04800731
What this trial is testing

Study of Lymphopenia as a Specific Biomarker or Prognostic Risk Factor for Disease Severity in Elderly Patients With COVID-19

Who this might be right for
LymphopeniaCovid19Older People
Universitair Ziekenhuis Brussel 227
Large-scale testing (Phase 3)Study completedNCT04435379
What this trial is testing

Study to Assess VPM1002 in Reducing Hospital Admissions and/or Severe Respiratory Infectious Diseases in Elderly in COVID-19 Pandemic

Who this might be right for
Infection, Respiratory Tract
Serum Life Science Europe GmbH 2,038
Testing effectiveness (Phase 2)Ended earlyNCT04240886
What this trial is testing

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds

Who this might be right for
Invasive Fungal Infections
Basilea Pharmaceutica 21
Early research (Phase 1)UnknownNCT05218070
What this trial is testing

Safety and Immunogenicity Study of EgyVax Vaccine Candidate for Prophylaxis of COVID-19 Infection

Who this might be right for
COVID-19
Eva Pharma 45
Large-scale testing (Phase 3)Ended earlyNCT04734873
What this trial is testing

CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients

Who this might be right for
Covid-19
Corvus Pharmaceuticals, Inc. 46
Not applicableStudy completedNCT05060562
What this trial is testing

Post Coronavirus Disease (COVID-19) Syndrome Indonesian Population

Who this might be right for
Covid19
Hasanuddin University 6,051
Testing effectiveness (Phase 2)Ended earlyNCT04748783
What this trial is testing

Antiviral Efficacy and Acceptability of Mouth Rinses for Inactivation of COVID-19

Who this might be right for
COVID19Coronavirus InfectionSARS CoV-2 Infection
University of North Carolina, Chapel Hill 2
Not applicableActive Not RecruitingNCT06654973
What this trial is testing

Singapore SARS-CoV-2 Human Challenge Study

Who this might be right for
COVID 19
Tan Tock Seng Hospital 20
Not applicableActive Not RecruitingNCT05813873
What this trial is testing

The Use of Incentive Spirometry in Adult Patients Hospitalised in a Rehabilitation Center With Long-covid Syndrome

Who this might be right for
Long COVID
European University Cyprus 70
Load More Results